title: A comparison of HIV seropositive and seronegative young adult heroin- and cocaine-using men who have sex with men in New York City, 2000-2003.
abstract: The purpose of this analysis was to determine the prevalence and correlates of HIV infection among a street-recruited sample of heroin- and cocaine-using men who have sex with men (MSM). Injection (injecting <or=3 years) and non-injection drug users (heroin, crack, and/or cocaine use <10 years) between 18 and 40 years of age were simultaneously street-recruited into two cohort studies in New York City, 2000-2003, by using identical recruitment techniques. Baseline data collected among young adult men who either identified as gay/bisexual or reported ever having sex with a man were used for this analysis. Nonparametric statistics guided interpretation. Of 95 heroin/ cocaine-using MSM, 25.3% tested HIV seropositive with 75% reporting a previous HIV diagnosis. The majority was black (46%) or Hispanic (44%), and the median age was 28 years (range 18-40). HIV-seropositive MSM were more likely than seronegatives to be older and to have an HIV-seropositive partner but less likely to report current homelessness, illegal income, heterosexual identity, multiple sex partners, female partners, and sex for money/drug partners than seronegatives. These data indicate high HIV prevalence among street-recruited, drug-using MSM compared with other injection drug use (IDU) subgroups and drug-using MSM; however, lower risk behaviors were found among HIV seropositives compared with seronegatives. Large-scale studies among illicit drug-using MSM from more marginalized neighborhoods are warranted.
authors.affiliation: Center for Urban Epidemiologic Studies, New York Academy of Medicine, 1216 5th Avenue, New York, NY 10029, USA. cfuller@nyam.org
authors.forename: Crystal M
authors.initials: CM
authors.lastname: Fuller
authors.forename: Judith
authors.initials: J
authors.lastname: Absalon
authors.forename: Danielle C
authors.initials: DC
authors.lastname: Ompad
authors.forename: Denis
authors.initials: D
authors.lastname: Nash
authors.forename: Beryl
authors.initials: B
authors.lastname: Koblin
authors.forename: Shannon
authors.initials: S
authors.lastname: Blaney
authors.forename: Sandro
authors.initials: S
authors.lastname: Galea
authors.forename: David
authors.initials: D
authors.lastname: Vlahov
mesh_terms: D000293:Adolescent; D000328:Adult; D019970:Cocaine-Related Disorders / Q000150:complications* / Q000208:ethnology; D015331:Cohort Studies; D004333:Drug Administration Routes; D005006:Ethnicity; D018023:HIV Seronegativity; D006679:HIV Seropositivity / Q000150:complications / Q000453:epidemiology* / Q000208:ethnology; D015528:HIV Seroprevalence; D015497:HIV-1; D006556:Heroin Dependence / Q000150:complications* / Q000208:ethnology; D018451:Homosexuality, Male; D006801:Humans; D008297:Male; D009519:New York City / Q000453:epidemiology; D012309:Risk-Taking; D012725:Sexual Behavior
references.citation: JAMA. 1994 Aug 10;272(6):449-54
references.pmid: 8040980
references.citation: Public Health Rep. 1998 Jun;113 Suppl 1:42-57
references.pmid: 9722809
references.citation: AIDS Educ Prev. 1998 Jun;10(3):278-92
references.pmid: 9642425
references.citation: J Acquir Immune Defic Syndr. 2004 Jun 1;36(2):734-42
references.pmid: 15167293
references.citation: MMWR Morb Mortal Wkly Rep. 2000 Jan 14;49(1):4-11
references.pmid: 10993566
references.citation: J Acquir Immune Defic Syndr. 2004 Feb 1;35(2):158-66
references.pmid: 14722449
references.citation: MMWR Morb Mortal Wkly Rep. 2003 Nov 28;52(47):1145-8
references.pmid: 14647015
references.citation: AIDS Care. 2003 Dec;15(6):829-37
references.pmid: 14617504
references.citation: Drugs Soc (New York). 1996;9(1-2):173-84
references.pmid: 12348010
references.citation: AIDS Educ Prev. 2003 Feb;15(1 Suppl A):39-52
references.pmid: 12630598
references.citation: Public Health Rep. 1998 Jun;113 Suppl 1:151-9
references.pmid: 9722820
references.citation: AIDS Educ Prev. 1996 Oct;8(5):415-29
references.pmid: 8911569
references.citation: J Acquir Immune Defic Syndr. 2001 Nov 1;28(3):264-9
references.pmid: 11694834
references.citation: Am J Public Health. 2001 Jun;91(6):907-14
references.pmid: 11392933
references.citation: J Acquir Immune Defic Syndr. 2004 Apr 15;35(5):526-36
references.pmid: 15021318
references.citation: J Acquir Immune Defic Syndr. 2002 Jan 1;29(1):76-85
references.pmid: 11782594
references.citation: Int J STD AIDS. 2004 Jan;15(1):33-7
references.pmid: 14769169
references.citation: Am J Public Health. 2003 Jun;93(6):862-5
references.pmid: 12773340
references.citation: J Urban Health. 2003 Dec;80(4 Suppl 3):iii26-39
references.pmid: 14713669
references.citation: AIDS Educ Prev. 2003 Feb;15(1 Suppl A):66-79
references.pmid: 12630600
references.citation: Am J Public Health. 2001 Jan;91(1):23-30
references.pmid: 11189819
references.citation: Am J Public Health. 2003 Jun;93(6):939-42
references.pmid: 12773359
references.citation: Am J Public Health. 2003 Jun;93(6):926-32
references.pmid: 12773357
references.citation: Am J Epidemiol. 1993 Sep 15;138(6):415-29
references.pmid: 8213747
references.citation: AIDS Behav. 2003 Jun;7(2):209-19
references.pmid: 14586205
references.citation: AIDS Educ Prev. 2003 Feb;15(1 Suppl A):1-6
references.pmid: 12630595
references.citation: J Acquir Immune Defic Syndr Hum Retrovirol. 1997;14 Suppl 2:S38-46
references.pmid: 9070513
references.citation: J Acquir Immune Defic Syndr. 2000 Sep 1;25(1):63-70
references.pmid: 11064506
references.citation: Am J Public Health. 2001 Jul;91(7):1060-8
references.pmid: 11441732
references.citation: AIDS Educ Prev. 2002 Dec;14(6):457-71
references.pmid: 12512847
references.citation: Am J Public Health. 2002 Mar;92(3):382-4
references.pmid: 11867315
references.citation: AIDS. 2000 Apr 14;14(6):717-26
references.pmid: 10807195
references.citation: Am J Epidemiol. 2002 Oct 1;156(7):641-53
references.pmid: 12244033
references.citation: Am J Public Health. 2003 Nov;93(11):1915-21
references.pmid: 14600066
references.citation: Am J Public Health. 1994 Dec;84(12):1933-7
references.pmid: 7998633
references.citation: Am J Public Health. 2001 Jun;91(6):922-6
references.pmid: 11392935
references.citation: Am J Public Health. 2000 Jul;90(7):1112-6
references.pmid: 10897190
references.citation: Am J Public Health. 1996 May;86(5):655-61
references.pmid: 8629715
references.citation: JAMA. 2000 Jul 12;284(2):198-204
references.pmid: 10889593
references.citation: J Acquir Immune Defic Syndr. 2003 Jan 1;32(1):86-93
references.pmid: 12514419
references.citation: Sex Transm Dis. 1998 Feb;25(2):100-7
references.pmid: 9518378
references.citation: AIDS Behav. 2004 Mar;8(1):17-23
references.pmid: 15146130
references.citation: Am J Public Health. 2001 Jun;91(6):927-32
references.pmid: 11392936
references.citation: J Black Psychol. 2004;30(1):78-105
references.pmid: 20041036
references.citation: J Womens Health Gend Based Med. 2001 May;10(4):371-80
references.pmid: 11445028
references.citation: AIDS. 2000 Aug 18;14(12):1793-800
references.pmid: 10985317
references.citation: AIDS Educ Prev. 2002 Dec;14(6):482-95
references.pmid: 12512849
references.citation: Public Health Rep. 2001;116 Suppl 1:136-45
references.pmid: 11889281
references.citation: J Natl Med Assoc. 1999 Feb;91(2):92-100
references.pmid: 10083778